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Recently, an rRNA-based polymerase chain reaction (PCR) has been developed for the detection of murine 
mycoplasmas at both the genus and species level (F. J. M. van Kuppeveld, J. T. M. van der Logt, A. F. Angulo,
M. J. van Zoest, W. G. V. Quint, H. G. Niesters, J. M. D. Galama, and W. J. G. Melchers, Appl. Environ. 
Microbiol. 58:2606-2615, 1992). In this study, the diagnostic value of this PCR assay for the detection of 
Mycoplasma pulmonis in infected rats was studied. For this purpose, 25 Wistar rats were infected intranasally 
with M. pulmonis strain M72-138 and investigated for the presence of this pathogen by both in vitro isolation 
and PCR. Five rats were monitored longitudinally by screening of throat swabs at several time points for up 
to 248 days postinfection. The remaining 20 rats were killed between 3 and 87 days postinfection, and organism 
recovery from both throat and urogenital tract specimens was attempted. M. pulmonis could be detected in the 
throat for up to 248 days postinfection but not in the urogenital tract, either by culture or by PCR. PCR proved 
to be the optimal method for testing throat samples. All samples in which M. pulmonis was detected by culture 
were also positive by PCR. By PCR, M. pulmonis was also detected in 3.7% of the samples which were culture 
negative and in 9.9% of the samples from which cultures were overgrown with bacteria. The results of this 
study demonstrate the suitability of PCR for the detection of mycoplasmal infection in rodents.
Mycoplasmal infections may cause severe problems in 
laboratory rodent colonies. Recent surveys indicate that 
about 60% of barrier-maintained and nearly all convention­
ally housed laboratory rat and mouse colonies are infected 
with one or more mycoplasmas (8, 10). The mycoplasmal 
species isolated from rats and mice (Mycoplasma pulmonis, 
M. arthritidis, M. neurolyticum, M. muris, and M. collis) 
have been associated with several disease manifestations. 
One of the main diseases is murine respiratory mycoplasmo­
sis, or chronic respiratory disease, which is caused by M. 
pulmonis and involves the nasal passages, middle ears, 
trachea, and lungs, causing rhinitis, otitis media, tracheitis, 
and pneumonia (5, 11). Besides respiratory disease, this 
organism can also produce genital infections, resulting in 
reduced birth rates (1, 5, 6). However, in spite of their 
pathogenic potential, mycoplasmal infections can remain 
inapparent. These inapparent infections may be very treach­
erous because mycoplasmas possess immunomodulatory 
activities which can influence the outcome of experiments 
(4,5). .
A first step in building and maintaining a mycoplasma-free 
colony is the use of an efficient detection system to routinely 
identify mycoplasma carriers (3). The methods currently 
used for the diagnosis of mycoplasmal infections show 
several shortcomings. In vitro isolation, which requires 
multisite culture for reliable results (3), is laborious and 
time-consuming and lacks sensitivity for several species, 
while serological methods are often hampered by cross­
reactions between different species (3, 4, 12). In addition, it 
has also been shown that animals can be infected and remain 
seronegative for weeks after infection (2).
Recently, we developed a polymerase chain reaction 
(PCR) assay for the detection of mycoplasmas at both the
* Corresponding author.
species and genus level (13). Primers selected from the 
variable 16S rRNA regions of the five murine mycoplasmal 
species were all species specific in this PCR assay. With a 
high copy number of rRNA (104 copies per cell), a highly 
sensitive assay was established in which the nucleic acid 
content equivalent to a single microorganism could be de­
tected (13).
In this study, the suitability of this PCR assay for the 
detection of mycoplasmal infection was tested in Wistar rats 
that were experimentally infected with M. pulmonis. We 
compared culture and the PCR assay for the detection of M. 
pulmonis in throat and urogenital tract samples collected at 
several times postinfection.
MATERIALS AND METHODS
Animals. Twenty-nine germ-free Cpb:WU (Wistar) rats, 
male and female, aged 10 weeks, were used. These rats are 
proven to be serologically negative for M. pulmonis. The 
rats were kept in sterile isolators and fed sterilized rat-mice 
food. Room temperature and humidity were regulated (21 ± 
2°C, 60% ± 10% relative humidity). The rats were housed in 
Macrolon cages, three animals per cage, with softwood 
granules as bedding. Noninfected control rats were housed 
separately from the experimentally infected rats.
Media. For cultivation in liquid and agar media, a modifi­
cation of the medium described by Chanock et al. (7) was 
used. The liquid culture medium contained (in milliliters per 
100 ml): 2.1% Bacto P.P.L.O. Broth (Difco), 70; 25% yeast 
extract (Difco), 10; 10% glucose (Merck), 10; inactivated 
gamma globulin-free horse serum (GIBCO), 5; P.P.L.O. 
serum fraction (Difco), 2; 0.1% phenol red (Sigma), 1; 2.5% 
thallium acetate (Merck), 1.4; and sodium penicillin G (105 
U/ml) (Gist-Brocades), 1. The pH was adjusted to 8.0 with 1 
NKOH.
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ml): 3.4% Bacto P.P.L.O. Agar (Difco), 70; inactivated 
gamma globulin-free horse serum, 20; 25% yeast extract, 10; 
10% glucose, 10; 0.1% phenol red, 4; and 2.5% thallium 
acetate, 2. The pH was adjusted to 8.0 with KOH.
Experimental inoculation of animals. The Af. pulmonis 
strain used for this study (M72-138) was originally isolated 
from the trachea of a rat from an infected laboratory colony. 
This strain was passaged three times on artificial medium. 
For this experiment, the mycoplasma was grown in liquid 
culture medium and harvested when the medium turned 
orange-red. The number of CFU was determined by titration 
on agar plates. The inoculum was kept at -80°C until use.
Twenty-five rats (rats 1 through 25) were experimentally 
infected with 106 CFU of M. pulmonis (in 100 jxl of culture 
medium) by intranasal inoculation. Four noninfected rats 
(rats 26 through 29), housed separately from the infected 
rats, were used as controls.
Evaluation of infection and collection of samples. At 14 time 
points (3, 7, 10, 14, 21, 31, 42, 59, 73, 87, 117, 151, 206, and 
248 days postinfection), throat swab samples were taken 
from rats 1 through 5. After 248 days, these rats were killed 
by cervical dislocation and urogenital swab samples (vaginal 
for female rats and urethral for male rats) were collected. 
Both throat and urogenital swab samples were collected at 
necropsy from rats 6 through 25, two of which were killed at 
each of the first 10 time points (3 to 87 days postinfection). 
Throat and urogenital swab samples were also taken from 
control rats 26 through 29, one of which was killed on each 
of days 7, 14, 21, and 59 postinfection.
The throat and urogenital swab samples were collected 
with sterile Dacron-tipped swabs (swab MW142; Medical 
Wire & Equipment Co. Ltd.). The swabs were suspended in 
2 ml of liquid culture medium. Half of the suspended swabs 
were used for culture, and the other half were placed at 
-80°C for PCR analysis.
PCR analysis. Samples (1 ml) obtained from the throat and 
urogenital swabs were centrifuged for 10 min at 10,000 x g. 
RNA was extracted by the RNAzol B method (Cinna Bio- 
tecx) according to the manufacturer’s instructions. cDNA  
synthesis of the RNA, the PCR assay, analysis of the 
amplified samples by electrophoresis, and subsequent hy­
bridization were performed as described previously (13). 
PCR was performed with M. pulmonis species-specific prim­
ers (sense primer, 5 ' -AGCGTTTGCTTCACTTTGAA-3 ' ; 
antisense primer, 5 ' -GGGCA1TTCCTCCCTAAGCT-3 ' ), 
which generate a 266-bp amplification product. The thermal 
profile involved 40 cycles of dénaturation at 94°C for 1 min, 
primer annealing at 55°C for 1 min, and primer extension at 
72°C for 2 min. Hybridization was performed with the 
internal 32P-end-labeled oligonucleotide GPO-1 (5'-ACTCCT 
ACGGG AGGCAGCAGT A-3 ' ).
Culture. The suspended throat and urogenital swab sam­
ples were incubated at 37°C until the color of the medium 
changed to orange-red. Cultures were incubated for 6 weeks 
before being considered negative.
Positive cultures were identified as M. pulmonis by PCR, 
since we had previously demonstrated (unpublished data) a 
100% correlation between identification of the organisms 
grown in culture medium by the growth inhibition test and 
identification by PCR with species-specific primers. For this 
PCR, DNA was extracted from the organisms grown in 
culture medium, and rDNA sequences were amplified as 
described previously (13), with the M. pulmonis-specific 
primers described above. Af. pulmonis was not demon­
strated in any of the cultures which did not display a change 
of color.




Rat 1 Rat 2 Rat 3 Rat 4 Rat 5
C P C P C P C P C P
3 + + + + + + + + + +
7 + + + + + + + + + +
10 + + + + + + + + + +
14 + + + + + + + + + +
21 + + + + + + + + + +
31 BC + + + BC + + + BC +
42 + + + + - - + + + +
59 + + + + - - + + + +
73 + + + + - - BC + + +
87 + + + + - - + + + +
117 + + + + - - + + + +
151 - - + + - - + + + +
206 + + + + - - + + + +
248 - + - + - - + + + +
a Throat swab samples were collected from rats 1 through 5 on the indicated 
days postinfection (p.i.) and tested for M. pulmonis by culture (C) and PCR 
(p)-
b BC, bacterial contamination.
ELISA. Routine enzyme-linked immunosorbent assays 
(ELISAs) for immunoglobulin G antibodies to Af. pulmonis 
were performed as described by Cassell et al. (3), with serum 
samples collected from rats 1 through 5 at the first 10 time 
points and from rats 6 through 29 on the day of death.
RESULTS
Culture and PCR analysis were compared for the detection 
of M. pulmonis in the throat and urogenital tract of 25 
experimentally infected Wistar rats. Infection of these rats 
was confirmed by ELISA for the detection of immunoglob­
ulin G antibodies against M. pulmonis (data not shown).
Rats 1 through 5 were investigated longitudinally for the 
presence of Af. pulmonis in the throat at several time points 
between 3 and 248 days postinfection. Table 1 demonstrates 
that with the PCR assay, which includes Southern blot 
analysis, M. pulmonis was detected in the throat of rats 1, 2,
4, and 5 at all time points investigated, while culture failed to 
detect Af. pulmonis in two samples (throat swabs from rats 1 
and 2 collected 248 days postinfection). The failure to detect 
Af. pulmonis in the throat of rat 1 at day 151 postinfection by 
both PCR and culture is probably the result of an error in 
collecting the sample, since subsequent samples were again 
positive for Af. pulmonis. Remarkably, Af. pulmonis was no 
longer detected in the throat of rat 3 from day 42 postinfec­
tion.
Rats 6 through 25 and control rats 26 through 29 were 
killed at various times postinfection and investigated for the 
presence of Af. pulmonis in both the throat and urogenital 
tract. The culture and PCR results, which are shown in Table
2, demonstrate that Af. pulmonis was detected in the throat 
of all infected rats but not in the control rats by PCR, 
whereas with the culture technique, the organism was 
missed in one sample (throat swab from rat 7, collected 3 
days postinfection). Table 2 also demonstrates that in none 
of the infected rats was Af. pulmonis detected in the urogen­
ital tract. Also, Af. pulmonis was not detected in the urogen­
ital tract of rats 1 through 5, which were killed 248 days 
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TABLE 2. Detection of Af. pulmonis by culture and PCR in 
throats and urogenital tracts of experimentally infected 
and noninfected control rats"
No. of positive samples/no. tested
Rat
group Throat Urogenital tract
Culture PCR Culture PCR
Infected 15/16* 20/20 0/20 0/20
Control 0/4 0/4 0/4 0/4
a Infected rats 6 through 25 and control rats 26 through 29 were killed at 
various times postinfection (see Materials and Methods), and swab samples 
were collected from the throat and urogenital tract at necropsy. 
b Bacterial overgrowth was observed in four cases.
Figure 1 shows an example of an electrophoretic analysis 
of the PCR products. Besides the 266-bp fragment, a smaller 
fragment (about 175 bp) was amplified in the RNA PCR 
which was not found in the DNA PCR. This 175-bp fragment 
also hybridized with the internal probe (data not shown). 
The origin of this smaller product is unknown. The addition 
of Perfect Match Enhancer (Stratagene), which destabilizes 
mismatched primer-template complexes, or dactinomycin, 
which reduces secondary RNA structures, did not prevent 
the amplification of this smaller product (data not shown).
DISCUSSION
In this study, the suitability of the 16S rRNA-based 
mycoplasmal PCR assay (13) as a tool for the diagnosis of 
mycoplasmal infection was examined in Wistar rats experi­
mentally infected with Af. pulmonis. In a preliminary study 
(data not shown), we had found that Af. pulmonis could be 
detected in throat swab samples of experimentally infected 
rats by PCR analysis. It was also found that the sensitivity 
was increased when the rRNA instead of the rDNA target 
was used, since the rDNA PCR failed to detect Af. pulmonis 
in some samples which were positive in the rRNA PCR. 
Therefore, in the current study, the rRNA PCR was per­
formed for the detection of Af. pulmonis.
Throat and urogenital tract swab samples were collected 
from 25 experimentally infected rats at several time points 
postinfection and tested by both PCR and in vitro isolation. 
The results demonstrate that Af. pulmonis was detected in 
the throat of all infected rats by PCR. By culture, Af. 
pulmonis was detected in only 70 (86.4%) of the 81 samples
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 18 17 18
FIG. 1. Agarose gel electrophoretic analysis of the PCR assay 
performed with RNA extracted from throat swab samples of rat 1 
(lanes 1, 6, and 11), rat 2 (lanes 2, 7, and 12), rat 3 (lanes 3, 8, and 
13), rat 4 (lanes 4, 9, and 14), and rat 5 (lanes 5,10, and 15) collected 
at 73 days (lanes 1 to 5), 87 days (lanes 6 to 10), and 117 days (lanes 
to 15) postinfection. Lane 16 and 17 show a negative and a 
positive (M pulmonis RNA) control, respectively. Lane 18 shows 
size markers (pBR322 digested with Hinü).
that were positive in the PCR. Bacterial overgrowth was 
observed in eight samples (9.9%), and Af. pulmonis was not 
detected by the culture method in three samples.
Detection of this mycoplasma in the respiratory tract for at 
least 248 days postinfection is consistent with the findings of 
Lindsey et al. (11), who reported that Af. pulmonis persisted 
in mice for several months. Why rat 3 was no longer positive 
for M. pulmonis after 31 days postinfection is unknown. In 
contrast to the throat samples, the urogenital tract samples 
of all rats were negative. It has been reported that it is 
extremely difficult to recover mycoplasmas from the genital 
tracts of male rats (9). However, since all the urogenital 
samples from female rats were also negative for Af. pulmo­
nis, it is most probable that the Af. pulmonis strain used in 
this experiment has not colonized the urogenital tract of 
these Wistar rats.
In summary, the results of this study indicate that PCR is 
superior to culture for the detection of Af. pulmonis in 
infected rats. These results therefore demonstrate the appli­
cability of this PCR assay for the detection of mycoplasmas 
in rodents. Currently, the diagnosis of mycoplasmal infec­
tions is performed by ELISA and/or in vitro isolation. In 
vitro isolation of mycoplasmas, which includes cultivation 
and identification, is laborious, time-consuming, and subject 
to bacterial contamination and lacks sensitivity for several 
mycoplasmal species. PCR, however, is a rapid, specific, 
and sensitive procedure. Therefore, PCR may replace in 
vitro isolation and become the method of choice in multisite 
screening programs to identify mycoplasma carriers. We are 
currently using this PCR assay to screen laboratory rodent 
colonies for naturally infected animals.
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